Filtros : "FÁRMACOS" "Financiamento FONDECyT" Removido: "PINOTTI, JOSE ARISTODEMO" Limpar

Filtros



Refine with date range


  • Source: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Subjects: ESPECTROFOTOMETRIA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CHAUCA, Enma Perez e PLASENCIA, Pedro M. Alva e FERRAZ, Humberto Gomes. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, v. 10, n. 5, p. 847-856, 2022Tradução . . Disponível em: https://doi.org/10.56499/jppres22.1433_10.5.847. Acesso em: 08 jun. 2024.
    • APA

      Chauca, E. P., Plasencia, P. M. A., & Ferraz, H. G. (2022). Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, 10( 5), 847-856. doi:10.56499/jppres22.1433_10.5.847
    • NLM

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jun. 08 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
    • Vancouver

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jun. 08 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847
  • Source: Frontiers in Pharmacology. Unidade: FCF

    Subjects: FÁRMACOS, MICRORNAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REYES, Pia Loren et al. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.831099. Acesso em: 08 jun. 2024.
    • APA

      Reyes, P. L., Saavedra, N., Torso, N. de G., Visacri, M. B., Moriel, P., & Salazar, L. A. (2022). Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, 13, 1-19. doi:10.3389/fphar.2022.831099
    • NLM

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jun. 08 ] Available from: https://doi.org/10.3389/fphar.2022.831099
    • Vancouver

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jun. 08 ] Available from: https://doi.org/10.3389/fphar.2022.831099
  • Source: Inorganic Chemistry Frontiers. Unidade: IFSC

    Subjects: ANTINEOPLÁSICOS, NEOPLASIAS, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEVÍN, Pedro et al. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, v. 8, n. 13, p. 3238-3252, 2021Tradução . . Disponível em: https://doi.org/10.1039/d1qi00233c. Acesso em: 08 jun. 2024.
    • APA

      Levín, P., Ruiz, M. C., Romo, A. I. B., Nascimento, O. R., Virgilio, A. L. D., Oliver, A. G., et al. (2021). Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug. Inorganic Chemistry Frontiers, 8( 13), 3238-3252. doi:10.1039/d1qi00233c
    • NLM

      Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1039/d1qi00233c
    • Vancouver

      Levín P, Ruiz MC, Romo AIB, Nascimento OR, Virgilio ALD, Oliver AG, Ayala AP, Diógenes ICN, León IE, Lemus L. Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug [Internet]. Inorganic Chemistry Frontiers. 2021 ; 8( 13): 3238-3252.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1039/d1qi00233c

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024